| 188568 |
CLINICAL AND MOLECULAR HEPATOLOGY |
Personalized treatment of hepatitis B |
2015-03-01 |
10.3350/cmh.2015.21.1.1 |
Lok, Anna S. |
| 188567 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan |
2015-03-01 |
10.2147/dddt.s62636 |
Tanimoto Tetsuya |
| 188566 |
JOURNAL OF BIOLOGICAL ENGINEERING |
Recent advances in 3D printing of biomaterials. |
2015-03-01 |
10.1186/s13036-015-0001-4 |
Chia Helena N, Wu Benjamin M |
| 188565 |
CLINICAL AND MOLECULAR HEPATOLOGY |
Recent advances in the imaging of hepatocellular carcinoma |
2015-03-01 |
10.3350/cmh.2015.21.1.95 |
You, Myung-Won, Kim, So Yeon, Kim, Kyoung Won, Lee, So Jung, Shin, Yong Moon, Kim, Jin Hee, Lee, Moon-Gyu |
| 188564 |
CLINICAL AND MOLECULAR HEPATOLOGY |
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells |
2015-03-01 |
10.3350/cmh.2015.21.1.49 |
Gu, Ha Ra, Park, Su Cheol, Choi, Su Jin, Lee, Jae Cheol, Kim, You Cheoul, Han, Chul Ju, Kim, Jin, Yang, Ki Young, Kim, Yeon Joo, Noh, Geum Youb, No, So Hyeon, Jeong, Jae-Hoon |
| 188563 |
CLINICAL AND MOLECULAR HEPATOLOGY |
Clinical implications of advances in liver regeneration |
2015-03-01 |
10.3350/cmh.2015.21.1.7 |
Kwon, Yong Jin, Lee, Kyeong Geun, Choi, Dongho |
| 188562 |
JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES |
Determining the Optimal Arc-Length for VMAT Treatment to the Prostatic-Bed |
2015-03-01 |
10.1016/j.jmir.2015.01.092 |
Rossall Andrew, Ostapiak Orest |
| 188561 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Neuroprotective therapies for glaucoma |
2015-03-01 |
10.2147/dddt.s80594 |
Song Wei, Huang Ping, Zhang Chun |
| 188560 |
PEDIATRIC BLOOD & CANCER |
Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML) |
2015-03-01 |
10.1002/pbc.25463 |
Nolt Dawn, Lindemulder Susan, Meyrowitz Jeffrey, Chang Bill H., Malempati Suman, Thomas Gregory, Stork Linda |
| 188559 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance |
2015-03-01 |
10.2147/dddt.s80451 |
Lindkær-Jensen Steen, Habib Lindkær-Jensen Nina, Larsen Stig, Fagertun Hans |
